Baicalin Reverses Depressive-Like Behaviours and Regulates Apoptotic Signalling Induced by Olfactory Bulbectomy

被引:42
作者
Yu, Hai-Yang [1 ]
Yin, Zhu-Jun [2 ]
Yang, Shui-Jin [2 ]
Ma, Shi-Ping [2 ]
Qu, Rong [1 ]
机构
[1] Nanjing Univ Chinese Med, Discipline Chinese & Western Integrat Med, Hanzhonglu 282, Nanjing 210046, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Tongjiaxiang 24, Nanjing 210009, Jiangsu, Peoples R China
关键词
baicalin; Apaf-1; caspase-9; caspase-3; apoptosis; olfactory bulbectomy; OXYGEN-GLUCOSE DEPRIVATION; RAT-BRAIN; NEURONAL DIFFERENTIATION; CYTOCHROME-C; STRESS; MODEL; ACTIVATION; CELLS; ANTIOXIDANT; RELEASE;
D O I
10.1002/ptr.5550
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Apoptosis is thought to be involved in neurological disorders including major depression. In this study, we examined whether the polyphenolic compound baicalin could decrease apoptosis in the olfactory bulbectomy (OBX) depression rat model. OBX rats exhibited decreased performance in depression-like behavioural tests and showed evidence of increased oxidative stress, decreased synaptophysin expression, and hippocampal apoptosis. Treatment with baicalin (20 and 40mg/kg) significantly reversed all of these changes. Baicalin modulated the levels or activity of malondialdehyde, superoxide dismutase, and glutathione peroxidase and prevented apoptotic protease-activating factor-1 expression, effectively suppressing caspase-mediated apoptosis signalling cascades. Our results demonstrate that baicalin has potent antidepressant activity, likely because of its ability to suppress apoptosis. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 32 条
[1]
Biomarkers of apoptosis:: Release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene [J].
Abu-Qare, AW ;
Abou-Donia, MB .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2001, 4 (03) :313-332
[2]
Arantes-Goncalves Filipe, 2006, Acta Med Port, V19, P9
[3]
Neuroprotective effect of baicalin on compression spinal cord injury in rats [J].
Cao, Yang ;
Li, Gang ;
Wang, Yan-feng ;
Fan, Zhong-kai ;
Yu, De-shui ;
Wang, Zai-de ;
Bi, Yun-long .
BRAIN RESEARCH, 2010, 1357 :115-123
[4]
Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain [J].
Che, Yi ;
Zhou, Zhu ;
Shu, Yuxin ;
Zhai, Chao ;
Zhu, Yuanyuan ;
Gong, Songjie ;
Cui, Yonghua ;
Wang, Jun-Feng .
NEUROSCIENCE LETTERS, 2015, 584 :208-213
[5]
Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo [J].
Cheng, Fafeng ;
Lu, Yi ;
Zhong, Xianggen ;
Song, Wenting ;
Wang, Xueqian ;
Sun, Xiaoguang ;
Qin, Jianguo ;
Guo, Shaoying ;
Wang, Qingguo .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
[6]
What causes the hippocampal volume decrease in depression? [J].
Czeh, Boldizsar ;
Lucassen, Paul J. .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (05) :250-260
[7]
Protective Effects of Baicalin on Aβ1-42-Induced Learning and Memory Deficit, Oxidative Stress, and Apoptosis in Rat [J].
Ding, Haitao ;
Wang, Haitao ;
Zhao, Yexia ;
Sun, Deke ;
Zhai, Xu .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2015, 35 (05) :623-632
[8]
Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: Involvement of antioxidant and anti-apoptotic mechanisms [J].
Ding, Lianshu ;
Zhang, Chong ;
Masood, Anbrin ;
Li, Jianxin ;
Sun, Jiao ;
Nadeem, Ahmed ;
Zhang, Han-Ting ;
O'Donnell, James M. ;
Xu, Ying .
BEHAVIOURAL BRAIN RESEARCH, 2014, 268 :150-158
[9]
Synaptic Dysfunction in Depression: Potential Therapeutic Targets [J].
Duman, Ronald S. ;
Aghajanian, George K. .
SCIENCE, 2012, 338 (6103) :68-72
[10]
Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons [J].
Ge, Qiu-Fu ;
Hu, Xin ;
Ma, Zhen-Qiu ;
Liu, Jian-Ren ;
Zhang, Wei-Ping ;
Chen, Zhong ;
Wei, Er-Qing .
PHARMACOLOGICAL RESEARCH, 2007, 55 (02) :148-157